How Much Did Redesign Health Raise? Funding & Key Investors

Date
April 25, 2025
Redesign Health

Total amount raised

$315 Millions

Latest funding date

Redesign Health

Location

Title

LINKEDIN

https://www.redesignhealth.com
Use Clay to find other emails
Status
Verified
Use Clay's email finder to get anyone's work email in seconds.

Redesign Health has successfully raised $175 million over multiple funding rounds, including a Series C, positioning itself as a unicorn with a valuation exceeding $1 billion. The venture builder focuses on launching and scaling transformative healthcare companies, addressing critical challenges in the healthcare sector.

Keep reading to explore the intricacies of Redesign Health's fundraising journey and the investors backing this innovative platform.

What Is Redesign Health?

Redesign Health, founded in 2018, is a venture builder based in New York, New York. The company focuses on the healthcare and venture capital industries, empowering founders to launch and scale transformative healthcare companies. With a team of 101-250 employees, Redesign Health has supported the creation of over 70 healthcare companies.

The company was founded by Brett Shaheen, Laura Bagnoli, Leann Arkema, and Susan Leonelli. Redesign Health leverages a proven model and various AI technologies to address critical challenges in the healthcare sector, impacting millions of patients and generating significant revenue.

How Much Funding Has Redesign Health Raised?

  1. Amount Raised: $250M
    • Date: March 2020
    • Lead Investors: Blisce, Declaration Partners
    • Valuation at Round: Not publicly disclosed
    • Motivation Behind the Round: To support the launch and scaling of transformative healthcare companies.
  2. Amount Raised: $65M
    • Date: September 2022
    • Lead Investors: General Catalyst
    • Valuation at Round: $1.7 billion
    • Motivation Behind the Round: To enhance Redesign Health's own operations and platform.

Total Amount Raised: $315M. Current Valuation: $1.7 billion.

Key Investors

  • General Catalyst
    • Details: General Catalyst is a venture capital firm that invests in powerful, positive change that endures. Hemant Taneja, General Catalyst CEO and managing director, has joined Redesign Health’s board.
    • Investment Focus Areas: Technology, healthcare, consumer, financial services.
    • Notable Investments: Airbnb, Stripe, Snap, Warby Parker.
  • Blisce
    • Details: Blisce is a growth-stage venture capital firm that partners with mission-driven entrepreneurs. The firm focuses on supporting companies that have a positive impact on society.
    • Investment Focus Areas: Technology, consumer, healthcare.
    • Notable Investments: Spotify, Pinterest, Headspace.
  • Declaration Partners
    • Details: Declaration Partners is an investment firm backed by the family office of David M. Rubenstein. The firm invests across various asset classes, including private equity and real estate.
    • Investment Focus Areas: Private equity, real estate, venture capital.
    • Notable Investments: Not explicitly mentioned.
  • CVS Health Ventures
    • Details: CVS Health Ventures is the venture capital arm of CVS Health, focusing on healthcare innovation. The firm aims to improve consumer healthcare experiences through innovative business models.
    • Investment Focus Areas: Healthcare innovation, consumer healthcare experiences.
    • Notable Investments: Not explicitly mentioned.
  • UPMC Enterprises
    • Details: UPMC Enterprises is the innovation and commercialization arm of UPMC, a healthcare provider. The firm focuses on developing and investing in healthcare innovations.
    • Investment Focus Areas: Healthcare innovation, commercialization.
    • Notable Investments: Not explicitly mentioned.

What's Next for Redesign Health?

Redesign Health stands at the cusp of significant opportunities, driven by its recent $65 million funding round. The company plans to leverage this capital to enhance its operations and platform, aiming to launch over 25 new healthcare startups this year. This ambitious goal aligns with the broader trend of increased investment in digital health, a sector that saw nearly $82 billion in venture capital in 2021.

Future fundraising opportunities appear promising, given the long-term potential of the healthcare field and the involvement of high-profile investors like General Catalyst and CVS Health Ventures. However, Redesign Health must navigate challenges such as the complexities of the healthcare industry and the current slowdown in venture capital investment due to macroeconomic concerns. Despite these hurdles, the company's innovative approach and strong partnerships position it well for continued growth and success.

Use Clay to Get Funding Data

Sales professionals, leverage Clay’s platform to access comprehensive fundraising data on companies like Redesign Health and gather other critical business insights. Sign up for free to start transforming your sales strategy today.

Share Article

Get access to more people and company data using Clay

Leverage the power of 100+ data providers for industry-leading data coverage & quality.

4.9 rating

Try for free

More Articles